Product Images Esomeprazole Magnesium

This is a description of a medication called Esomeprazole Magnesium Delayed-Release Capsules, USP. Each capsule contains 20 mg of the medicine. The NDC number is 83301-0006-3 and each package comes with 1000 capsules. It is a prescription medicine and the pharmacist is advised to provide a medication guide to each patient. The dosage information is mentioned in the package insert. The capsules should be stored at a temperature of 25°C (77°F) with excursions permitted from 15° to 30°C (59° to 86°F). The container must be kept tightly closed and out of reach of children. The medicine was manufactured for Mullan Pharmaceutical Inc. in Pasadena, CA 91101, and manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China, 052160. The given text does not provide enough information to interpret the purpose of the text starting from "€9000 TO€€8|", thus it is not usable.*

Each capsule contains 20 mg of esomeprazole, a medication used to treat gastroesophageal reflux disease (GERD) and other conditions caused by excess stomach acid. The dosage information is provided in the package insert, and the recommended storage temperature is between 15°C to 30°C. The container should be kept out of reach of children. These capsules are manufactured by Mullan Pharmaceutical Inc. and distributed by CSPC Ouyi Pharmaceutical Co., Ltd. The product is available in a package of 90 capsules. This text also contains some irrelevant characters resulting from errors.*

This is a medication package for Esomeprazole Magnesium Delayed-Release Capsules, USP. The package insert contains dosage information and storage instructions. The medication should be stored at a temperature range of 15°C to 30°C. It is important to keep the container tightly closed and out of reach of children. The accompanying medication guide should be dispensed to each patient by the pharmacist. The medication is manufactured by CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China, and distributed by Mullan Pharmaceutical Inc. in Pasadena, CA.*

Esomeprazole Magnesium is a prescription drug available in the form of delayed-release capsules, containing 40mg of esomeprazole per capsule. The package contains 1000 capsules that should be stored at the temperature range from 15°C to 30°C. Dispense the medication guide to every patient. The drug is manufactured by CSPC Ouyi Pharmaceutical Co. in China, while it is distributed by Mullan Pharmaceutical, Inc. in Pasadena, CA. This drug is used to treat gastroesophageal reflux disease (GERD) and other similar gastrointestinal diseases.*

This is a medication package insert for Esomeprazole Magnesium Delayed-Release Capsules. It includes dosage information and storage instructions, with recommended temperature and precautions. The medication should be kept out of reach of children and the accompanying Medication Guide should be provided to each patient by the pharmacist. The medication is manufactured for Mullan Pharmaceutical Inc. and manufactured in China by CSPC Ouyi Pharmaceutical Co, Ltd. Expiration date and batch number are also provided.*

Each capsule contains 40 mg of esomeprazole and is stored between 15°C to 30°C (59°F to 86°F). Patients are advised to check the package for dosage information. The drug is manufactured by Mullan Pharmaceutical Inc. in Pasadena, CA and CSPC Ouyi Pharmaceutical Co., Ltd. in Shijiazhuang, Hebei, China. The container must be tightly closed and kept out of children's reach. The product is sold as 90 capsules. Pharmacists must dispense the medication guide with the product to each patient.*

This appears to be a table or graph presenting the percentage of maintenance for Esomeprazole Magnesium in different dosages (10 mg, 20 mg, and 40 mg) among a sample size of 77-82 individuals. The percentage maintained is consistently 8, except for one instance where it is 3.*

This is a chart showing the percentage of patients who are symptom-free in intervals of 25%. There is no specific information available about what type of symptoms or patients are being evaluated.*